Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The present and future of vaccination for cutaneous leishmaniasis.

× No keyword cloud information.

37 in total

1. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.

Authors: Salvador Iborra; Javier Carrión; Charles Anderson; Carlos Alonso; David Sacks; Manuel Soto
Journal: Infect Immun Date: 2005-09 Impact factor: 3.441

Review 2. Sex-associated hormones and immunity to protozoan parasites.

Authors: C W Roberts; W Walker; J Alexander
Journal: Clin Microbiol Rev Date: 2001-07 Impact factor: 26.132

3. Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors: Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal: Eur J Immunol Date: 2009-01 Impact factor: 5.532

4. Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice.

Authors: D Frommel; B W Ogunkolade; I Vouldoukis; L Monjour
Journal: Infect Immun Date: 1988-04 Impact factor: 3.441

5. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.

Authors: E Handman; F M Symons; T M Baldwin; J M Curtis; J P Scheerlinck
Journal: Infect Immun Date: 1995-11 Impact factor: 3.441

6. Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.

Authors: Susana Mendez; Khaled Tabbara; Yasmine Belkaid; Sylvie Bertholet; Daniela Verthelyi; Dennis Klinman; Robert A Seder; David L Sacks
Journal: Infect Immun Date: 2003-09 Impact factor: 3.441

7. BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.

Authors: Laura Ramírez; Salvador Iborra; Jimena Cortés; Pedro Bonay; Carlos Alonso; Manoel Barral-Netto; Manuel Soto
Journal: J Biomed Biotechnol Date: 2010-01-26

The present and future of vaccination for cutaneous leishmaniasis.